^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PF-06940434

    i
    Other names: PF-06940434
    Associations
    News
    Trials
    Company:
    Pfizer
    Drug class:
    αVβ8 integrin inhibitor
    Related drugs:
    Associations
    News
    Trials